text: Dental service organisations (DSOs) have been bitten hard by the pandemic. A senior executive at Great Expressions Dental Centers told Third Bridge Forum of almost entirely disappearing volumes: “We were down 95%... and the 5% accounting for the offices that we chose to keep open just to service emergencies.”
  Click on the hyperlink below to access the full Forum transcript.
  The ins and outs of dental service organisations during the COVID-19 outbreak
  However, the specialist noted that there has since been a bounce-back, largely from continuity of care. As demand is “definitely there”, the specialist believes that any organisation that wasn’t able to benefit from the surge could have been dealing with operational issues. “Staffing is the major, major issue right now… A lot of people didn’t want to come back.”
  The discussion moved on to the requirements for dentist’s offices to function in this environment. The specialist explained that the CDC’s guidelines include both mandates and recommendations, which need to be untangled. In addition, public demand needs to be assessed, including how comfortable people feel and the extra time needed, as well as the resulting impact on footfall.
  The specialist was asked about the scope for a pick-up in private label consumables and implants. Adoption differs when it comes to providers and patients, as well as the product. In general, “patients don’t care”, unless it’s a favoured brand like Invisalign. Consequently, “there is a big opportunity for a lot more private label products to stock in my shelves at a significant cost saving.”
  Implants are another consumer preference taking hold. While previous generations were more accepting of dentures, baby boomers, who have higher disposable income and better healthcare knowledge, are driving demand. This uptake could be further supported by third-party financing.
  Other topics covered in this Interview included what impact DSOs could have on the dental lab business and the benefits of converting the branding of acquired practices.
  To access all the human insights from Third Bridge Forum’s DSO Market Update – Coronavirus Impact, Volume Trends & H2 2020 Outlook Interview, click here to view the full transcript.
  Related Transcripts
  FORUM TRANSCRIPT
  DSO Market Update – Coronavirus Impact, Volume Trends & H2 2020 Outlook – 23 July 2020
  Multi Asset
  Healthcare
  North America
  PREMIUM
  The information used in compiling this document has been obtained by Third Bridge from experts participating in Forum Interviews. Third Bridge does not warrant the accuracy of the information and has not independently verified it. It should not be regarded as a trade recommendation or form the basis of any investment decision.
  For any enquiries, please contact sales@thirdbridge.com
  Additional Content	
  Sector Report
  Q3 2021: another landmark year for gene editing
  Public Equity
  Healthcare
  North America
  Interview Synopsis
  One Call Care Management – COVID-19 impact & 2020 outlook
  Multi Asset
  Healthcare
  North America
  Interview Synopsis
  Influenza vaccines – next-generation mRNA vaccines & market update – part 2
  Public Equity
  Healthcare
  North America
  Interview Synopsis
  NuVasive Medical Devices – competitive analysis & Q4 2020 outlook
  Multi Asset
  Healthcare
  North America
  Interview Synopsis
  Healthcare analytics platforms – Inovalon, Optum & Cotiviti – innovation trends & consolidation outlook